Ikonisys launches the Ikoniscope Max in Europe

Paris, France – September 9, 2024 – Ikonisys SA (Euronext Growth Paris: ALIKO), a specialist in early and accurate cancer detection, is launching its new Ikoniscope Max in Europe. This cutting-edge digital microscope will be showcased at the 36th European Congress of Pathology in Florence.

The Ikoniscope Max promises to set a new standard in digital pathology with unmatched accuracy and automation. Leveraging Ikonisys’ world-leading automated FISH technology, it meets the growing productivity and diagnostic needs of laboratories.

Francesco Trisolini, Ikonisys’ Chief Operating Officer, expressed his enthusiasm for the launch. The product will be presented in Florence, offering pathologists a first experience of this cutting-edge technology.

In addition, Ikonisys will present a diagnostic approach combining liquid-based cytology (LBC) and automated fluorescence in situ hybridization (FISH). This combination could improve early detection of cancers, particularly in large-scale screening programs.

Congress attendees will be able to experience the Ikoniscope Max and attend detailed demonstrations by Ikonisys experts.